Premier Diagnostic Health Services Inc.

Premier Diagnostic Health Services Inc.

August 05, 2011 09:20 ET

PDH to Hold Investor Information Sessions

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 5, 2011) -


Premier Diagnostic Health Service Inc. ("PDH") (CNSX:PDH) today announced that it will hold upcoming investor information sessions in connection with a proposed non-brokered private placement offering. Details of the private placement offering will be announced by PDH next week.

The sessions for investors in British Columbia and Alberta will take place during the weeks of August 8th and 15th and will outline the Company's new business plan and PDH's proposed private placement. The sessions will consist of a presentation, Q&A period, and the option for continued discussion.

More details about the investor sessions are available on the Company's website

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier.

About Premier Diagnostic Health Services Inc. ("PDH")

The Company is engaged in developing and operating diagnostic imaging clinics in Canada and China, with a focus on PET-CT Scanning ("Positron Emission Tomography – Computed Tomography"). Premier is committed to providing the latest technology to enhance health options and owns and operates the first and only private PET-CT clinic in Western Canada as well as an MRI clinic in collaboration with No. 3 Military Police Hospital in Beijing, China. The Centre for Advanced Diagnostics in Burnaby offers access to the most advanced medical imaging technology available in cancer care today, and is dedicated to meeting today's healthcare needs through delivering exceptional patient care.

The Canadian National Stock Exchange has neither approved nor disapproved the contents of this press release.

Contact Information